What is the recommended test for diagnosing neurosyphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Tests for Diagnosing Neurosyphilis

The diagnosis of neurosyphilis requires cerebrospinal fluid (CSF) examination with VDRL-CSF as the standard serological test, which is considered diagnostic when reactive in the absence of blood contamination. 1, 2

Diagnostic Approach

  • No single test can diagnose all cases of neurosyphilis; diagnosis relies on a combination of serological tests, CSF abnormalities, and clinical manifestations 3, 1
  • CSF examination is the cornerstone of neurosyphilis diagnosis and should include:
    • VDRL-CSF (standard serological test) 3, 1, 2
    • CSF cell count (typically elevated >5 WBCs/mm³ in neurosyphilis) 3, 1
    • CSF protein levels (often elevated) 2, 4

VDRL-CSF Test Characteristics

  • VDRL-CSF is highly specific (90.3-99.3%) for neurosyphilis when reactive 4
  • A reactive VDRL-CSF in the absence of blood contamination is considered diagnostic 3, 1
  • However, VDRL-CSF has limited sensitivity (49-87%), meaning a negative result does NOT exclude neurosyphilis 1, 4
  • Sensitivity varies by neurosyphilis type: 85.7-100% in symptomatic cases vs. 62.5-69.6% in asymptomatic cases 4

Additional Recommended Tests

  • FTA-ABS test on CSF is recommended by some experts 3, 1
    • Less specific than VDRL-CSF (more false positives) 3, 1
    • Highly sensitive - a negative CSF FTA-ABS test may exclude neurosyphilis 3, 1
  • CSF leukocyte count is a sensitive measure of disease activity and treatment effectiveness 3, 2
    • Typically elevated >5 WBCs/mm³ in neurosyphilis 3, 1
    • A count >10 cells/μL plus reactive CSF-VDRL strongly supports the diagnosis 2

Important Considerations and Limitations

  • False-positive VDRL-CSF results are rare but can occur with CNS tumors and meningeal carcinomatosis 4
  • Blood contamination during lumbar puncture can affect results (≥3 lambda of syphilitic blood can produce false-positive VDRL-CSF) 4
  • Sequential serologic tests (VDRL or RPR) should be performed using the same testing method, preferably by the same laboratory 3
  • Recent research suggests RPR could be an alternative to VDRL for CSF testing, with comparable specificity (99.3% vs. 99%) and sensitivity (75% vs. 70.8%) 5
  • PCR testing for Treponema pallidum in CSF has excellent specificity (97-100%) but limited sensitivity (27-42.5%) 6, 7

Special Populations

  • In HIV-infected patients:
    • Serologic tests are generally accurate and reliable for diagnosis 3
    • However, interpretation should be careful as these patients may have abnormal serologic results (unusually high, low, or fluctuating titers) 3, 2
    • Consider additional tests (biopsy, direct microscopy) in HIV patients with clinical syndromes suggestive of early syphilis 3

Diagnostic Algorithm

  1. Perform serological tests for syphilis (VDRL/RPR and treponemal tests) 4
  2. If positive, proceed to lumbar puncture for CSF analysis 2, 4
  3. Evaluate CSF for:
    • VDRL-CSF (primary diagnostic test) 3, 1, 2
    • CSF leukocyte count (typically >5 WBCs/mm³) 3, 2
    • CSF protein levels 2, 4
    • Consider CSF FTA-ABS (if VDRL-CSF is negative but suspicion remains high) 3, 1

References

Guideline

Diagnóstico y Seguimiento de Neurosífilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing and Treating Neurosyphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnóstico de Neurosífilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.